Table 2.

Effects of WHP on the space exploration capability of the open-field test.

Groups	No. of Squares Crossed	No. of Rearing	No. of Inner Squares Entered	Time Spent in Inner Squares (s)	No. Fecal Boli
Control	108.25 ± 18.59	18.13 ± 4.94	2.38 ± 1.51	1.31 ± 0.88	0.88 ± 1.13
Model control	45.38 ± 27.83 a	5.50 ± 4.11 a	0.88 ± 0.99	0.88 ± 0.83	1.13 ± 1.13
Whey protein	94.88 ± 34.71	13.25 ± 6.16 b	2.25 ± 2.12	1.50 ± 1.20	0.63 ± 0.92
WHP-LG	74.13 ± 14.09	13.63 ± 8.68 b	1.13 ± 1.81	15.88 ± 42.09	1.63 ± 1.60
WHP-MG	98.25 ± 26.18 b	14.00 ± 10.41 b	1.38 ± 1.19	1.00 ± 0.76	1.50 ± 1.41
WHP-HG	121.38 ± 47.88 b	15.63 ± 8.67 b	2.25 ± 0.89	1.63 ± 0.52	1.00 ± 1.20

Data are expressed as means ± SD (n = 8). ^a p < 0.05 indicates significant difference versus the control group; ^b p < 0.05 indicates significant difference versus the model group. Whey protein group at a dose of 1.5 g/kg; WHP-LG, whey protein peptide low dose group at a dose of 0.3 g/kg; WHP-MG, whey protein peptide medium dose group at a dose of 1.5 g/kg; WHP-HG, whey protein peptide high dose group at a dose of 3.0 g/kg.